STATE STREET CORP - PHATHOM PHARMACEUTICALS INC ownership

PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 85 filers reported holding PHATHOM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of PHATHOM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$6,922,971
-8.8%
667,596
+26.0%
0.00%
Q2 2023$7,587,352
+129.1%
529,843
+14.3%
0.00%
Q1 2023$3,311,125
-67.3%
463,743
-48.6%
0.00%
Q4 2022$10,128,272
+105.2%
902,698
+102.6%
0.00%
Q3 2022$4,936,000
+43.0%
445,495
+9.0%
0.00%
Q2 2022$3,451,000
-30.5%
408,882
+12.0%
0.00%
Q1 2022$4,968,000
-26.1%
365,044
+6.8%
0.00%
Q4 2021$6,726,000
-40.9%
341,940
-3.6%
0.00%
-100.0%
Q3 2021$11,388,000
-1.1%
354,764
+4.2%
0.00%0.0%
Q2 2021$11,519,000
+41.2%
340,303
+56.7%
0.00%
Q1 2021$8,158,000
+17.5%
217,198
+3.9%
0.00%
Q4 2020$6,945,000
-11.6%
209,050
-2.5%
0.00%
-100.0%
Q3 2020$7,859,000
+12.2%
214,307
+0.7%
0.00%0.0%
Q2 2020$7,003,000
+44.8%
212,807
+13.6%
0.00%
Q1 2020$4,836,000
+24.0%
187,308
+49.6%
0.00%
Q4 2019$3,900,000125,2430.00%
Other shareholders
PHATHOM PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Medicxi Ventures Management (Jersey) Ltd 3,760,869$39,000,21212.45%
Frazier Life Sciences Management, L.P. 10,109,279$104,833,2236.96%
Decheng Capital Management III (Cayman), LLC 850,000$8,814,5002.94%
Carlyle Group Inc. 3,496,808$36,191,9631.57%
Ghost Tree Capital, LLC 395,000$4,096,1501.35%
Newtyn Management, LLC 500,000$5,185,0001.28%
Altium Capital Management LP 220,000$2,281,4001.19%
StepStone Group LP 422,085$4,377,0210.98%
MPM BioImpact LLC 347,332$3,601,8330.96%
NEA Management Company, LLC 1,276,595$12,238,2900.94%
View complete list of PHATHOM PHARMACEUTICALS INC shareholders